Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.88% is 12% below its 5-year average of 3.28%, around the middle of its 5-year range (1.17%–5.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.95% below its 12-month average of 3.23%.
Reported quarterly debt to assets ratio; no daily interpolation. Q3 FY2026 (2026-06-30): 2.88%.
DEBT TO ASSETS RATIO
2.88%
DEBT TO ASSETS RATIO AVG TTM
3.23%
DEBT TO ASSETS RATIO AVG 3Y
2.84%
DEBT TO ASSETS RATIO AVG 5Y
3.28%
DEBT TO ASSETS RATIO AVG 10Y
3.03%
DEBT TO ASSETS RATIO AVG 15Y
2.02%
DEBT TO ASSETS RATIO AVG 20Y
1.56%
CURRENT VS TTM AVG
-10.95%
CURRENT VS 3Y AVG
+1.16%
CURRENT VS 5Y AVG
-12.29%
CURRENT VS 10Y AVG
-4.92%
CURRENT VS 15Y AVG
+42.15%
CURRENT VS 20Y AVG
+83.83%
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 465 covered companies
CURRENT VS SECTOR MEDIAN
+2514.89%
vs the sector median at left
Market Cap
$1.96B
Debt to Assets Ratio
0.75%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.01B
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.02B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.05B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.89B
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Azenta, Inc. (AZTA) | $1.97B | 2.88% | 3.23% | 2.84% | 3.28% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | 0.75% | N/A | N/A | N/A |
| Absci Corporation (ABSI)vs › | $1.95B | 0.01% | N/A | N/A | N/A |
| AxoGen, Inc. (AXGN)vs › | $2.00B | 0.07% | N/A | N/A | N/A |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | 0.41% | N/A | N/A | N/A |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 0.08% | N/A | N/A | N/A |
| Immunome, Inc. (IMNM)vs › | $2.02B | 0.01% | N/A | N/A | N/A |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 0.03% | N/A | N/A | N/A |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 0.04% | N/A | N/A | N/A |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.06B | 0.73% | N/A | N/A | N/A |
Debt/Assets
2.9%
Debt/Equity
0.04
Current Ratio
2.50
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.88% |
| 2026-03-31 | 2.93% |
| 2025-12-31 | 5.25% |
| 2025-09-30 | 2.49% |
| 2025-06-30 | 2.61% |
| 2025-03-31 | 2.63% |
| 2024-12-31 | 2.66% |
| 2024-09-30 | 3.37% |
| 2024-06-30 | 5.68% |
| 2024-03-31 | 2.89% |
| 2023-12-31 | 2.35% |
| 2023-09-30 | 2.09% |
| 2023-06-30 | 4.38% |
| 2023-03-31 | 3.84% |
| 2022-12-31 | 3.45% |
| 2022-09-30 | 1.32% |
| 2022-06-30 | 1.25% |
| 2022-03-31 | 1.17% |
| 2021-12-31 | 5.04% |
| 2021-09-30 | 5.21% |
| 2021-06-30 | 5.37% |
| 2021-03-31 | 4.98% |
| 2020-12-31 | 5.22% |
| 2020-09-30 | 5.28% |
| 2020-06-30 | 5.30% |
| 2020-03-31 | 5.27% |
| 2019-12-31 | 4.57% |
| 2019-09-30 | 3.37% |
| 2019-06-30 | 36.24% |
| 2019-03-31 | 36.53% |
| 2018-12-31 | 36.13% |
| 2018-09-30 | 17.89% |
| 2018-06-30 | 18.00% |
| 2018-03-31 | 18.46% |
| 2017-12-31 | 19.97% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 1.03% |
| 2015-03-31 | 1.06% |
| 2014-12-31 | 1.08% |
| 2014-09-30 | 1.07% |
| 2014-06-30 | 1.06% |
| 2014-03-31 | 1.11% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 2.35% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 2.60% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 15.47% |
| 2006-03-31 | 15.77% |
| 2005-12-31 | 16.17% |
| 2005-09-30 | 28.04% |
| 2005-06-30 | 27.33% |
| 2005-03-31 | 27.08% |
| 2004-12-31 | 26.84% |
| 2004-09-30 | 26.08% |
| 2004-06-30 | 26.58% |
| 2004-03-31 | 26.81% |
| 2003-12-31 | 28.72% |
| 2003-09-30 | 35.54% |
| 2003-06-30 | 31.98% |
| 2003-03-31 | 30.86% |
| 2002-12-31 | 29.30% |
| 2002-09-30 | 26.64% |
